Literature DB >> 28058176

Consideration of a Safe Protocol for Hepatocyte Transplantation Using Infantile Pigs.

Shin Enosawa1, Wenji Yuan1, Masaharu Douzen1, Atsuko Nakazawa2, Takeshi Omasa3, Akinari Fukuda4, Seisuke Sakamoto4, Takanobu Shigeta4, Mureo Kasahara4.   

Abstract

Hepatocyte transplantation is hoped to be an alternative treatment to certain cases of liver transplantation. The most promising indication is for congenital metabolic diseases, especially in infants. To establish a safe protocol for hepatocyte transplantation into infants, we examined physiological changes during treatment using infantile pigs. Recipient pigs (domestic, crossbred with Large-Yorkshire, Landrace, and Duroc; 2.5 kg; 7-14 days old) were anesthetized with isoflurane; a midline incision of minimum length provided access to the superior mesenteric vein. A double lumen catheter was inserted through the vein to within 1 cm of the hepatic portal region. Physiological parameters such as heart rate, systemic blood pressure, and portal pressure were monitored. Cryopreserved porcine hepatocytes isolated from the same strain were suspended in physiological saline and transfused through the catheter. In experiments requiring tracing, cells were stained with fluorescent dye prior to transfusion. Recipient pigs were kept for 1 day and sacrificed for histological liver examination. After preliminary experiments, the optimized number and concentration for hepatocyte transplantation were determined to be 1 × 108 cells/kg and 1 × 107 cells/ml. The cell suspension was transfused at a rate of 0.67 ml/min. No marked anomaly of physiological parameters was observed, whereas light tachycardia occurred in preliminary trials when the transfusion rate was faster than our standard protocol. All five pigs transfused with the established method recovered from anesthesia and survived with good vital signs. Histology revealed that the transfused hepatocytes were integrated in the hepatic tissue.

Entities:  

Keywords:  Hepatocyte transplantation; Infantile pigs; Safe protocol

Year:  2012        PMID: 28058176      PMCID: PMC5196922          DOI: 10.3727/215517912X639469

Source DB:  PubMed          Journal:  Cell Med        ISSN: 2155-1790


  6 in total

Review 1.  Preparation of isolated rat liver cells.

Authors:  P O Seglen
Journal:  Methods Cell Biol       Date:  1976       Impact factor: 1.441

Review 2.  Human hepatocyte transplantation: worldwide results.

Authors:  Robert A Fisher; Stephen C Strom
Journal:  Transplantation       Date:  2006-08-27       Impact factor: 4.939

3.  International trial of the Edmonton protocol for islet transplantation.

Authors:  A M James Shapiro; Camillo Ricordi; Bernhard J Hering; Hugh Auchincloss; Robert Lindblad; R Paul Robertson; Antonio Secchi; Mathias D Brendel; Thierry Berney; Daniel C Brennan; Enrico Cagliero; Rodolfo Alejandro; Edmond A Ryan; Barbara DiMercurio; Philippe Morel; Kenneth S Polonsky; Jo-Anna Reems; Reinhard G Bretzel; Federico Bertuzzi; Tatiana Froud; Raja Kandaswamy; David E R Sutherland; George Eisenbarth; Miriam Segal; Jutta Preiksaitis; Gregory S Korbutt; Franca B Barton; Lisa Viviano; Vicki Seyfert-Margolis; Jeffrey Bluestone; Jonathan R T Lakey
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

4.  The significant improvement of survival times and pathological parameters by bioartificial liver with recombinant HepG2 in porcine liver failure model.

Authors:  Shin Enosawa; Tomoyuki Miyashita; Tomohiro Saito; Takeshi Omasa; Toshiharu Matsumura
Journal:  Cell Transplant       Date:  2006       Impact factor: 4.064

5.  Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation.

Authors:  Helena Johansson; Agneta Lukinius; Lisa Moberg; Torbjörn Lundgren; Christian Berne; Aksel Foss; Marie Felldin; Ragnar Källen; Kaija Salmela; Annika Tibell; Gunnar Tufveson; Kristina Nilsson Ekdahl; Graciela Elgue; Olle Korsgren; Bo Nilsson
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

6.  Hepatocyte transplantation for glycogen storage disease type Ib.

Authors:  Kwang-Woong Lee; Ji-Hyun Lee; Sung Wook Shin; Sung Joo Kim; Jae Won Joh; Doo-Hoon Lee; Jong-Won Kim; Hwa-Young Park; Soo-Youn Lee; Hwan Hyo Lee; Jin Wan Park; Shi-Yeon Kim; Hee-Hoon Yoon; Doo-Hee Jung; Yon Ho Choe; Suk-Koo Lee
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

  6 in total
  5 in total

1.  Evaluation of Urea Cycle Activity by Metabolic Flux Analysis Using Mass Spectrometry.

Authors:  Yasuharu Ueno; Takuji Maeda; Satoshi Okamoto; Hideki Taniguchi
Journal:  Methods Mol Biol       Date:  2022

2.  Hepatocyte Transplantation to the Liver via the Splenic Artery in a Juvenile Large Animal Model.

Authors:  J Siefert; K H Hillebrandt; S Moosburner; P Podrabsky; D Geisel; T Denecke; J K Unger; B Sawitzki; S Gül-Klein; S Lippert; P Tang; A Reutzel-Selke; M H Morgul; A W Reske; S Kafert-Kasting; W Rüdinger; J Oetvoes; J Pratschke; I M Sauer; N Raschzok
Journal:  Cell Transplant       Date:  2019-12-17       Impact factor: 4.064

Review 3.  Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine.

Authors:  Charlotte A Lee; Siddharth Sinha; Emer Fitzpatrick; Anil Dhawan
Journal:  J Mol Med (Berl)       Date:  2018-04-24       Impact factor: 4.599

4.  The Regenerative Effect of Portal Vein Injection of Liver Organoids by Retrorsine/Partial Hepatectomy in Rats.

Authors:  Tomonori Tsuchida; Soichiro Murata; Koichiro Matsuki; Akihiro Mori; Megumi Matsuo; Satoshi Mikami; Satoshi Okamoto; Yasuharu Ueno; Tomomi Tadokoro; Yun-Wen Zheng; Hideki Taniguchi
Journal:  Int J Mol Sci       Date:  2019-12-26       Impact factor: 5.923

5.  Investigation of Clinical Safety of Human iPS Cell-Derived Liver Organoid Transplantation to Infantile Patients in Porcine Model.

Authors:  Tomonori Tsuchida; Soichiro Murata; Shunsuke Hasegawa; Satoshi Mikami; Shin Enosawa; Huai-Che Hsu; Akinari Fukuda; Satoshi Okamoto; Akihiro Mori; Megumi Matsuo; Yumi Kawakatsu; Hitomi Matsunari; Kazuaki Nakano; Hiroshi Nagashima; Hideki Taniguchi
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.